A panel of leading vaccine experts has backed the Covid-19 vaccine for kids age 5 to 11 from Pfizer Inc. and BioNTech SE....
A panel of leading vaccine experts has backed the Covid-19 vaccine for kids age 5 to 11 from Pfizer Inc. and BioNTech SE....
It’s a relative of the delta variant, identified by British scientists last month. Because it isn't a variant of interest or concern, it...
Pfizer Inc and BioNTech SE have asked U.S. regulators to authorize their COVID-19 vaccine for emergency use in children aged 5-11, with an...
A panel of expert advisers to the U.S. Food and Drug Administration unanimously voted on Thursday to recommend booster shots of Moderna Inc's...
The U.S. Food and Drug Administration on Wednesday is pushing to cut salt levels by an average of 12% in food ranging from...
Older adults without heart disease shouldn't take daily low-dose aspirin to prevent a first heart attack or stroke, an influential health guidelines group...
The World Health Organization on Monday recommended that immunocompromised people be given an additional dose of COVID-19 vaccine, due to their higher risk...
Merck & Co Inc said on Monday it has applied for emergency use authorization in the United States for its oral drug to...
AstraZeneca's experimental COVID-19 drug has helped cut the risk of severe disease or death in a late-stage study, the British drugmaker said on...
Moderna Inc said on Friday it aims to deliver one billion doses of its COVID-19 vaccine to low-income countries in 2022, in addition...
The head of BioNTech SE, the German company that developed the first Covid-19 vaccine, said a new formula is likely to be needed...
The European Union's drug regulator on Friday identified a possible link between rare cases of blood clotting in deep veins with Johnson &...
Merck & Co Inc's experimental oral drug for COVID-19, molnupiravir, reduced by around 50% the chance of hospitalization or death for patients at...
Russians may soon be able to receive vaccines not registered in the country from clinics set up in a special economic zone, Russian...
YouTube will block all anti-vaccine content, moving beyond its ban on false information about the coronavirus vaccines to include content that contains misinformation...
Laboratory studies show that Merck & Co's experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the...
AstraZeneca will take full control of Caelum Biosciences in a deal worth up to $500 million, the drugmaker said on Wednesday, as it...
Japan will lift a state of emergency in all regions on Thursday as the number of new cases falls, while India reported the...